CARGO Therapeutics, Inc.
CRGX
$4.12
$0.071.73%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 10.63M | 11.18M | 11.86M | 10.30M | 7.89M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 50.13M | 47.11M | 49.32M | 40.81M | 34.96M |
| Operating Income | -50.13M | -47.11M | -49.32M | -40.81M | -34.96M |
| Income Before Tax | -45.44M | -41.91M | -44.35M | -35.81M | -32.08M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -45.44M | -41.91M | -44.35M | -35.81M | -32.08M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -45.44M | -41.91M | -44.35M | -35.81M | -32.08M |
| EBIT | -50.13M | -47.11M | -49.32M | -40.81M | -34.96M |
| EBITDA | -49.35M | -46.40M | -48.71M | -40.25M | -34.43M |
| EPS Basic | -0.95 | -0.88 | -1.02 | -0.87 | -1.49 |
| Normalized Basic EPS | -0.59 | -0.55 | -0.64 | -0.55 | -0.93 |
| EPS Diluted | -0.95 | -0.88 | -1.02 | -0.87 | -1.49 |
| Normalized Diluted EPS | -0.59 | -0.55 | -0.64 | -0.55 | -0.93 |
| Average Basic Shares Outstanding | 47.83M | 47.66M | 43.34M | 41.00M | 21.56M |
| Average Diluted Shares Outstanding | 47.83M | 47.66M | 43.34M | 41.00M | 21.56M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |